KLBF — To expand radiopharmaceutical facility in Surabaya

KLBF — To expand radiopharmaceutical facility in Surabaya Kalbe Farma Tbk (KLBF), through its subsidiary Global Onkolab Farma (GOF), has begun constructing a new radiopharmaceutical production facility in Surabaya. This facility is specifically for Fluorodeoxyglucose (FGD), a key component in early cancer detection. It will be KLBF's second facility, following a similar one established in Jakarta. The project aligns with Indonesia's national goals to boost pharmaceutical independence and is expected to begin operating in 2025. The facility will provide critical support for PET/CT-Scan services in hospitals, enhancing access to comprehensive cancer care. (Source : Kontan)